Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial

Robert S. Kirsner(Hershey (United States)), Herbert B. Slade(University of North Texas), Tommy D. Lee, Robert Snyder(Barry University), William A. Marston(University of North Carolina at Chapel Hill), D. Innes Cargill
The Lancet
August 3, 2012
Cited by 173


Related Papers